Champignon Brands Inc. SHRMF Archives - Page 3 of 4

ThursdayMay 21, 2020 12:14 pm

Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Expands into US Through Acquisition of Leading Ketamine Center

SHRM announces recent acquisition of California-based Ketamine Wellness Clinic of Orange County Inc. CEO calls acquisition major milestone as company accelerates vision of establishing sizable footprint of integrated ketamine clinics Center is recognized leader in ketamine infusion therapy, research and complementary treatment protocols With the announcement of its recent acquisition of the Ketamine Wellness Clinic of Orange County Inc., Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) is taking steps to expand into the United States (http://ibn.fm/rFEOp). The wellness clinic owns and operates a state-of-the-art ketamine infusion treatment center located within the Mission Hospital’s Laguna Beach campus. “We are thrilled…

WednesdayMay 20, 2020 12:51 pm

Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Announces Appointment of New CEO, Board Member

SHRM appoints top depression researcher as new chief executive officer McIntyre established Canada’s first-ever center to provide rapid-onset treatments for individuals with mood disorders Champignon also announces appointment of new board member Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a Canada-based company dedicated applying novel and natural treatment protocols with an emphasis on psychedelic medicine, has appointed one of the world’s top researchers on depression as its new chief executive officer (http://ibn.fm/rureS). In his new role, Dr. Roger McIntyre brings impressive experience in the ketamine and psychedelic medicine space, a key focus area for Champignon. “My overarching aim as…

MondayMay 18, 2020 9:57 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Collaborates with TheraPsil to Help Patients in Palliative Care Access New Therapies

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences Company with an emphasis on ketamine and psychedelic medicine, today announced its sponsorship of TheraPsil, a BC-based non-profit coalition of healthcare professionals, policy-makers and community leaders (the “TheraPsil Coalition”) seeking legal access to psilocybin for British Columbians with a palliative diagnosis and psychological distress. According to the update, TheraPsil is focused on: establishing safe, and legal access to psychedelic-assisted therapy for those in medical need, efforts to increase awareness and developing safe and effective protocols for psilocybin-assisted therapy through public education and educational training, as well facilitating research…

WednesdayMay 13, 2020 9:33 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) to Acquire Wellness Clinic of Orange County, Advancing North American Clinical Expansion

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, on Tuesday announced the execution of a term sheet with California-based Wellness Clinic of Orange County Inc., further advancing the company’s North American clinical expansion. Per the term sheet, SHRMF is to acquire 100% of the Wellness Clinic and all of its subsidiaries in exchange for payments over an 18-month period totaling: (a) USD $600,000; (b) 1 million common shares of Champignon (the “Initial Share Issuance”); and, (C) 500,000 common shares of Champignon payable only if the Wellness Clinic…

MondayMay 11, 2020 9:58 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Appointment of Dr. Roger McIntyre as Chief Executive Officer

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences Company with an emphasis on ketamine and psychedelic medicine, today announced its appointment of Dr. Roger McIntyre as its Chief Executive Officer. Among several additional roles, Dr. McIntyre is a Professor of Psychiatry and Pharmacology at the University of Toronto and Head of the Mood Disorders Psychopharmacology Unit at the University Health Network, Toronto. “We are extremely pleased and fortunate to be able to bring Dr. McIntyre aboard as CEO,” Champignon Director Gareth Birdsall stated in the news release. “Dr. McIntyre’s is the world’s leading authority on depression…

WednesdayMay 06, 2020 9:26 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Names New President, Secretary; Appoints New Member to Board of Directors

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced the appointment of Pat McCutcheon to the company’s board of directors, effective immediately. McCutcheon is currently the chief executive officer of one of the leading global cannabis companies, MediPharm Labs Corp. (TSX: LABS), and has held senior roles with various large pharmaceutical companies. Champignon also announced the appointment of Matthew Fish, JD as president and secretary. In his private practice as a…

TuesdayMay 05, 2020 11:33 am

Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496) Chosen as Headline Partner for Psychedelics Symposium

Established as an industry leader in psychedelics, chosen as headline partner for PSYCH Importance of mental health has been brought to the forefront during COVID-19 pandemic Changing public opinion of psychedelics for medicinal purposes with help of psychedelic events such as PSYCH Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a research-driven company specializing in the formulation and distribution of a suite of artisanal mushroom health supplements, will be the headline partner for Prohibition Partners LIVE’s PSYCH: The Psychedelics Symposium (PSYCH) (http://ibn.fm/YBNMG). Slated for June 22-23, 2020, this Prohibition Partners LIVE event brings together health care, science and business…

MondayMay 04, 2020 2:00 pm

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Forms Dedicated Committee to Advance North American Clinical Expansion

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company focused on applying novel and natural treatment protocols to address a broad range of disorders and deficiencies with an emphasis on psychedelic medicine, today announced it has advanced its North American new clinical entity (“NCE”) expansion stratagem via the formation of a dedicated planning committee (the “Committee”). “We will look to capitalize on the fragmented nature of the U.S. ketamine clinic marketplace with the objective of creating a consortium of integrated mood disorder treatment and research facilities,” Gareth Birdsall, CEO of Champignon, said in the news release.…

ThursdayApr 30, 2020 10:33 am

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Complete Vertical Integration of Ketamine Treatments/Therapies, Closing of AltMed Acquisition

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) continues to strengthen its vertically integrated psychedelic medicine ecosystem via the acceleration of its ketamine topicals prescription fulfillment capabilities. The company today announced the addition of central fill and compounding infrastructure for its proprietary ketamine formulations via a location at one of Canada’s leading retail pharmacy chains (the “Pharmacy”), as well as the dispensing of its products throughout the Pharmacy’s network. “With this arrangement, Champignon boasts complete vertical integration with respect to our rapid onset ketamine treatments and therapies,” Champignon CEO Gareth Birdsall stated in the news release. “From novel formulations to product…

WednesdayApr 29, 2020 12:15 pm

Champignon Brands Inc.’s (CSE: SHRM) (OTC: SHRMF) (FWB: 496) New Committee Member Strengthens Compentencies

SHRM appoints former Red Bull Canada president to Special Advisory Committee New member’s background in heavily regulated industries coupled with experience in CPG space provides great complement Effective immediately, Champignon common shares being traded on OTCQB Venture Market Champignon Brands Inc. (CSE: SHRM) (OTC: SHRMF) (FWB: 496), a Canada-based company dedicated to applying novel and natural treatment protocols with an emphasis on psychedelic medicine, announced the appointment of Jim Bailey as a new member of its Special Advisory Committee. The appointment of Bailey, a former president of Red Bull Canada, is designed to strengthen SHRM’s pharmaceutical, nutraceutical and CPG marketing/distribution…

Site Search

Company Search

Tag: Champignon Brands Inc. SHRMF